Omada Health initiated with an Outperform at Citizens

Citizens initiated coverage of Omada Health (OMDA) with an Outperform rating and $18 price target Omada is a leading, next-generation virtual care provider, the analyst tells investors in a research note. The firm says the company’s scaled platform is “diversified and backed by rigorous clinical studies.” While the company has had “robust” membership growth, it still is “only scratching the surface,” contends Citizens.